Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 11/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | INMT | O95050 | 2/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1147831 | 0.82 | TSHR (0.42) | MEN1KMT2ASMN1; SMN2KDM4ELMNA | |
| SCHEMBL26620226 | 0.81 | HCAR2 (0.49) | MEN1KMT2AHCAR2SMN1; SMN2ATM | |
| SCHEMBL19029793 | 0.81 | HCAR2 (0.49) | MEN1KMT2AHCAR2SMN1; SMN2ATM | |
| SCHEMBL19029776 | 0.81 | HCAR2 (0.49) | MEN1KMT2AHCAR2SMN1; SMN2ATM | |
| SCHEMBL15871832 | 0.79 | TSHR (0.42) | MEN1KMT2ASMN1; SMN2LMNAGAA | |
| SCHEMBL24939801 | 0.77 | MEN1 (0.44) | MEN1KMT2AHCAR2SMN1; SMN2ATM | |
| SCHEMBL19048925 | 0.75 | HCAR2 (0.42) | MEN1KMT2AHCAR2ATMBLM | |
| SCHEMBL24938802 | 0.75 | HCAR2 (0.49) | MEN1KMT2AHCAR2SMN1; SMN2LMNA | |
| SCHEMBL24939690 | 0.75 | TSHR (0.39) | MEN1KMT2ASMN1; SMN2KDM4ELMNA | |
| SCHEMBL12655475 | 0.74 | BLM (0.49) | MEN1KMT2AHCAR2SMN1; SMN2INMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230022129-A1 | RESIST MATERIAL AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230022129-A1 | RESIST MATERIAL AND PATTERNING PROCESS | GFER, LBR, PCNA | MEN1 1589/4885KMT2A 1415/4885HCAR2 601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.